An Randomized Controlled Trial (RCT) Testing the Effectiveness of a Hybrid Emotion-focused Treatment for Chronic Pain Patients With Co-occurring Emotional Problems
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chronic Pain
- Sponsor
- Örebro University, Sweden
- Enrollment
- 115
- Locations
- 2
- Primary Endpoint
- Multidimensional Pain Inventory (MPI) change
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The aim of this project is to evaluate a hybrid emotion-focused treatment protocol, specifically developed for individuals who suffer from co-occurring chronic pain and clinical levels of anxiety and/or depressive symptoms.
Specific questions relating to treatment outcome:
-
Does a hybrid emotion-focused treatment lead to a decrease in comorbid emotional symptoms (pain-related fear, anxiety, depression)?
-
Does a hybrid emotion-focused treatment lead to an increase in functional ability, improvement in work status and decrease in medication use?
-
Does a hybrid emotion-focused treatment lead to better treatment effect on the above outcome variables compared to an active comparison group?
Specific questions relating to the process of change:
-
Are therapeutic effects of the hybrid emotion-focused treatment mediated by changes in proposed transdiagnostic emotion regulation process variables (worry, rumination, cognitive and behavioral avoidance, emotional suppression)?
Detailed Description
Design. A randomized controlled trial in which chronic pain patients with co-occurring emotional problems will receive either: 1. A hybrid individual treatment combining emotion regulation focused Dialectical Behavior Therapy (DBT) with standard exposure methodology. The treatment targets the transdiagnostic psychological processes that have been shown to maintain emotional dysregulation. 2. An active control condition receiving internet-delivered pain management treatment based on Cognitive Behavioral principles. This treatment is evidence-based and thus provides a credible and ethical active comparison group. Selection. N=84 (ES=.5, p=.05 and ß=.80; based on an estimated between group difference on the Hospital Anxiety and Depression Scale, and compensating for an approximate drop out rate of 20% per condition). Patients will be recruited through pain rehabilitation units in Orebro and Linkoping and via advertisements in the local newspapers. Procedure. Patients will be examined and screened by trained professionals to exclude individuals with red flags (serious medical illnesses that explain pain conditions), a risk of suicide, and/or need of emergency psychiatric care. After screening and baseline assessment, participants will be randomized to receive either the individual face-to-face hybrid emotion focused treatment (10-15 weekly or biweekly sessions) or the individual, guided, internet-based Cognitive Behavior Therapy (iCBT) treatment for pain (10 weekly sessions). The internet treatment is therapist guided through email contact. The hybrid treatment will be conducted by a trained and supervised licensed clinical psychologist and the internet guidance will be provided by trained and supervised clinical psychologists in their final stage of clinical training. The hybrid emotion-focused treatment integrates procedures from exposure and DBT with a clear uniting conceptualization focused on targeting underlying processes that maintain co-occurring chronic pain and emotional problems.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Chronic musculoskeletal pain (\> 6 months duration), not emanating from malignancies, systemic diseases (e.g. rheumatoid arthritis) or localized single-joint osteoarthritic conditions in the lower extremities (e.g. knee-osteoarthritis, hip- osteoarthritis).
- •Functional problems due to pain (defined as \> 10 points on question 21-24 of the Orebro Musculoskeletal Pain Questionnaire).
- •Emotional problems (defined as \>7 points (cut-off for a probable case) on at least one of the two subscales (anxiety and depression) of the Hospital Anxiety and Depression Scale).
Exclusion Criteria
- •Severe psychiatric disorders that may require immediate other treatment (alcohol abuse, bipolar disorder, psychotic disorders),
- •Currently in psychological treatment elsewhere,
- •Recently been started on psychopharmacological treatment for depression and/or anxiety (cut off criterion: \< 3 months prior to planned treatment start),
- •Insufficient mastery of the Swedish language written as well as spoken,
- •No personal computer available.
Outcomes
Primary Outcomes
Multidimensional Pain Inventory (MPI) change
Time Frame: baseline, 3 months, 12 months
change in pain intensity and interference (from pretreatment, to post treatment and follow up). Subscale pain intensity range 0-12, subscale pain interference range 0-66 (for both subscales higher values worse outcome)
Montgomery Asberg depression rating scale (MADRS) change
Time Frame: baseline, 3 months, 12 months
change in self rated depression (from pretreatment, to post treatment and follow up) Scale range 0-60 (higher values worse outcome)
Pain Catastrophizing Scale (PCS) change
Time Frame: baseline, 3 months, 12 months
change in pain catastrophizing (from pretreatment, to post treatment and follow up). Scale range 0-52 (higher values worse outcome).
Generalised Anxiety Disorder 7-item Scale (GAD-7) change
Time Frame: baseline, 3 months, 12 months
change in general anxiety (from pretreatment, to post treatment and follow up). Scale range 0-27 (higher values worse outcome).
Secondary Outcomes
- The Behavior Activation for Depression Scale (BADS) change(baseline, 1.5 months, 3 months)
- Tampa Scale for Kinesiophobia (TSK) change(baseline, 3 months)
- Lisat 11 change(baseline, 3 months, 12 months)
- Difficulties in Emotion Regulation Scale (DERS) change(baseline, 1.5 months, 3 months)
- Chronic Pain Acceptance Questionnaire (CPAQ) change(baseline, 3 months)
- Self-Compassion scale-12 (SCS) change(baseline, 3 months)
- Insomnia Severity Index (ISI) change(baseline, 3 months)